https://scholars.lib.ntu.edu.tw/handle/123456789/514960
標題: | Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension | 作者: | Mulatero P. Sechi L.A. Williams T.A. Lenders J.W.M. Reincke M. Satoh F. Januszewicz A. Naruse M. Doumas M. Veglio F. VIN-CENT WU Widimsky J. |
公開日期: | 2020 | 出版社: | NLM (Medline) | 卷: | 38 | 期: | 10 | 起(迄)頁: | 1929-1936 | 來源出版物: | Journal of hypertension | 摘要: | : Primary aldosteronism is a frequent cause of secondary hypertension requiring a specific pharmacological treatment with mineralocorticoid receptor antagonist or with unilateral adrenalectomy. These treatments have shown to reduce the excess of cardiovascular risk characteristically associated with this disease. In part I of this consensus, we discussed the procedures for the diagnosis of primary aldosteronism. In the present part II, we address the strategies for the differential diagnosis of primary aldosteronism subtypes and therapy. We also discuss the evaluation of outcomes and provide suggestions for follow-up as well as cardiovascular and metabolic complications specifically associated with primary aldosteronism. Finally, we analyse the principal gaps of knowledge and future challenges for research in this field. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090376081&doi=10.1097%2fHJH.0000000000002520&partnerID=40&md5=b7528c470ead3a43cda48ba93fbc9f53 https://scholars.lib.ntu.edu.tw/handle/123456789/514960 |
ISSN: | 1473-5598 | DOI: | 10.1097/HJH.0000000000002520 | SDG/關鍵字: | mineralocorticoid antagonist; adrenalectomy; complication; consensus; genetics; human; hyperaldosteronism; hypertension; Adrenalectomy; Consensus; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。